Living Cell Valuation
| LVCLF Stock | USD 0 0 166.67% |
Living Cell seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Living Cell Technologies from analyzing the firm fundamentals such as Operating Margin of (428.70) %, return on equity of -0.72, and Shares Outstanding of 1.29 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Living Cell's price fluctuation is out of control at this time. Calculation of the real value of Living Cell Technologies is based on 3 months time horizon. Increasing Living Cell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Living pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Living Cell Technologies. Since Living Cell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Living Pink Sheet. However, Living Cell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.004 | Real 0.003809 | Hype 0.003434 |
The real value of Living Pink Sheet, also known as its intrinsic value, is the underlying worth of Living Cell Technologies Company, which is reflected in its stock price. It is based on Living Cell's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Living Cell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Living Cell Technologies helps investors to forecast how Living pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Living Cell more accurately as focusing exclusively on Living Cell's fundamentals will not take into account other important factors: Living Cell Total Value Analysis
Living Cell Technologies is now expected to have takeover price of 12.53 M with market capitalization of 9.81 M, debt of 228.44 K, and cash on hands of 4.24 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Living Cell fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.53 M | 9.81 M | 228.44 K | 4.24 M |
Living Cell Investor Information
About 34.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. Living Cell Technologies had not issued any dividends in recent years. Living Cell Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Living Cell Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Living Cell has an asset utilization ratio of 0.0797 percent. This implies that the Company is making $7.97E-4 for each dollar of assets. An increasing asset utilization means that Living Cell Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Living Cell Ownership Allocation
Living Cell Technologies maintains a total of 1.29 Billion outstanding shares. Living Cell Technologies holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Living Cell Profitability Analysis
The company reported the revenue of 3.4 K. Net Loss for the year was (1.96 M) with profit before overhead, payroll, taxes, and interest of 3.4 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Living Cell's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Living Cell and how it compares across the competition.
About Living Cell Valuation
The pink sheet valuation mechanism determines Living Cell's current worth on a weekly basis. Our valuation model uses a comparative analysis of Living Cell. We calculate exposure to Living Cell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Living Cell's related companies.Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. The company was founded in 1987 and is based in Sydney, Australia. Living Cell operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Living Cell's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Living Cell's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Living Cell's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Living Cell's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Living Cell's revenue streams: Identify Living Cell's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Living Cell's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Living Cell's growth potential: Evaluate Living Cell's management, business model, and growth potential.
- Determine Living Cell's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Living Cell's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Living Cell Growth Indicators
Investing in growth stocks can be very risky. If the company such as Living Cell does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.3 B | |
| Retained Earnings | -78.7 M |
Complementary Tools for Living Pink Sheet analysis
When running Living Cell's price analysis, check to measure Living Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Living Cell is operating at the current time. Most of Living Cell's value examination focuses on studying past and present price action to predict the probability of Living Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Living Cell's price. Additionally, you may evaluate how the addition of Living Cell to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |